Folates in Trypanosoma brucei: Achievements and Opportunities

ChemMedChem
Gregorio CulliaAndrea Pinto

Abstract

Trypanosoma brucei is the agent of human African trypanosomiasis (HAT), a neglected disease that threatens the lives of 65 million people in sub-Saharan Africa every year. Unfortunately, available therapies are unsatisfactory, due primarily to safety issues and development of drug resistance. Over the last decades significant effort has been made in the discovery of new potential anti-HAT agents, with help from the World Health Organization (WHO) and private-public partnerships such as the Drugs for Neglected Diseases Initiative (DNDi). Whereas antifolates have been a valuable source of drugs against bacterial infections and malaria, compounds effective against T. brucei have not yet been identified. Considering the relatively simple folate metabolic pathway in T. brucei, along with results obtained in this research field so far, we believe that further investigations might lead to effective chemotherapeutic agents. Herein we present a selection of the more promising results obtained so far in this field, underlining the opportunities that could lead to successful therapeutic approaches in the future.

References

Nov 1, 1989·Antimicrobial Agents and Chemotherapy·J D BermanN Edwards
Jan 1, 1988·Molecular and Biochemical Parasitology·N Yarlett, C J Bacchi
Jan 1, 1984·American Journal of Medical Genetics·R W Erbe, J C Wang
Sep 28, 1998·Journal of Computer-aided Molecular Design·F ZuccottoI H Gilbert
Nov 2, 1999·Journal of Medicinal Chemistry·S F ChowdhuryI H Gilbert
Jul 14, 2001·European Journal of Medicinal Chemistry·F ZuccottoI H Gilbert
Jun 27, 2002·Biochimica Et Biophysica Acta·Ian H Gilbert
Apr 10, 2003·Journal of Enzyme Inhibition and Medicinal Chemistry·Shafinaz F ChowdhuryIan H Gilbert
Oct 8, 2003·Current Pharmaceutical Design·John J McGuire
Oct 15, 2003·Bioorganic & Medicinal Chemistry·Didier PezIan H Gilbert
Oct 29, 2003·Trends in Parasitology·Alan H Fairlamb
Mar 1, 2005·Pharmacological Reviews·Aric Gregson, Christopher V Plowe
Oct 23, 2008·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Goro KikuchiKoichi Hiraga
Oct 17, 2009·Lancet·Reto BrunChristian Burri
Nov 18, 2009·Journal of Medicinal Chemistry·Lindsay B TullochWilliam N Hunter
May 5, 2010·Antimicrobial Agents and Chemotherapy·Antoaneta Y SokolovaAlan H Fairlamb
Jun 4, 2010·PLoS Neglected Tropical Diseases·Oliver YunFrançois Chappuis
Jun 16, 2010·Molecular Microbiology·Natasha SienkiewiczAlan H Fairlamb
Dec 3, 2010·PLoS Pathogens·Isabel M VincentMichael P Barrett
Jun 3, 2011·Molecular Microbiology·Angela RoldánR Luise Krauth-Siegel
Jun 10, 2011·ACS Chemical Biology·Jarunee VanichtanankulYongyuth Yuthavong
Jul 9, 2011·PLoS Neglected Tropical Diseases·Robert T JacobsRobert Don
Aug 24, 2011·Future Medicinal Chemistry·Robert T JacobsRobert Don
Oct 1, 2011·Future Microbiology·Michael P BarrettEnock Matovu
Oct 26, 2011·Essays in Biochemistry·Tim J Vickers, Stephen M Beverley
Jul 10, 2014·Journal of Medicinal Chemistry·Abedawn I KhalafWilliam N Hunter
Oct 21, 2016·The Journal of Biological Chemistry·Simon DewarAlan H Fairlamb
Jul 5, 2017·Lancet·Philippe BüscherGerardo Priotto
Oct 25, 2017·The FEBS Journal·Remo S SchmidtPascal Mäser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.